Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)
NCT00367315 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1684
Last updated 2012-05-21
Summary
This study will evaluate the efficacy and safety of using lumiracoxib in the treatment of patients with knee osteoarthritis (OA)
Conditions
Interventions
- DRUG
-
Lumiracoxib
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-09-30
- Primary Completion
- 2004-02-29
Countries
- Germany
- Switzerland
Study Locations
More Related Trials
-
52 Week, International, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Clinical Trial to Compare Retention on Treatment, Safety, Tolerability & Efficacy of Lumiracoxib 100 mg od, Lumiracoxib 100 mg Bid & Celecoxib 200 mg od in Pts With Primary OA of Hip, Knee, Hand or Spine
NCT00145301 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip Osteoarthritis
NCT00154219 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee Surgery
NCT00333567 ·Status: COMPLETED ·Phase: PHASE4
-
Safety of Lumiracoxib in Patients With Osteoarthritis
NCT00637949 ·Status: COMPLETED ·Phase: PHASE3
-
Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee
NCT00137410 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension
NCT00267176 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)
NCT00092352 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Celecoxib Versus Placebo in the Treatment of Patients With Osteoarthritis of the Knee Who Were Unresponsive to Naproxen and Ibuprofen
NCT00640627 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Celecoxib Versus Naproxen in the 6-month Treatment of Knee Osteoarthritis
NCT00643799 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Celecoxib 200mg in Relieving Pain and Walking Dysfunction in Osteoarthritis of the Knee
NCT00597415 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)
NCT00092365 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Korean Participants With Osteoarthritis
NCT01554163 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
NCT00120900 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability and Preliminary Efficacy of Multiple Intra-articular Injections of LRX712 in Patients With Knee OA
NCT04097379 ·Status: COMPLETED ·Phase: PHASE2
-
Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)
NCT00242489 ·Status: COMPLETED ·Phase: PHASE2
-
Celebrex Total Knee Arthroplasty Study
NCT00359151 ·Status: TERMINATED ·Phase: PHASE4
-
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee
NCT00689273 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen
NCT00638807 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, Pharmacokinetics and -Dynamics of Multiple Rising Oral Doses of BI 113823 in Patients Patients With Osteoarthritis of the Knee
NCT01207973 ·Status: TERMINATED ·Phase: PHASE1
-
Effectiveness and Safety of Celecoxib (Celebrex 200 mg) Combined With Joins in the Treatment of Degenerative Knee Osteoarthritis: a Randomized Controlled Trial
NCT04718649 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (United States)
NCT00620867 ·Status: COMPLETED ·Phase: PHASE4
-
Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part II
NCT01598415 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)
NCT00092781 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of MEDI7352 in Participants With Painful Osteoarthritis of the Knee
NCT04675034 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety and Efficacy of an Investigational Drug in Patients With Osteoarthritis (0663-071)(COMPLETED)
NCT00269191 ·Status: COMPLETED ·Phase: PHASE3